SEATTLE GENETICS INC Business Operations Contracts & Agreements
52 Contracts & Agreements
- Collaboration Agreements (19 contracts)
- Development Agreements (17)
- Services Agreements (1)
- Supply Agreements (14)
- Termination Agreements (1)
- Amendment No. 1 to Commercial Supply Agreement dated June 17, 2022 between Seagen Inc. (f/k/a Seattle Genetics, Inc.) and Corden Pharma GmbH (Filed With SEC on July 28, 2022)
- Thirteenth Amendment to Development and Supply Agreement, effective May 12, 2022 between Seagen Inc. (f/k/a Seattle Genetics, Inc.) and AbbVie Inc. (formerly part of Abbott... (Filed With SEC on July 28, 2022)
- Tenth Amendment to Development and Supply Agreement, effective as of December 26, 2016 between (Filed With SEC on February 9, 2022)
- Collaboration and License Agreement dated January 7, 2007 between (Filed With SEC on February 9, 2022)
- Commercial Supply Agreement between Hovione Farmaciencia, SA and Seagen Inc. dated July 1, 2021 (Filed With SEC on October 28, 2021)
- Ninth Amendment to Development and Supply Agreement effective as of August 28, 2016 between Seagen Inc. (f/k/a Seattle Genetics, Inc.) and AbbVie Inc. (formerly part of Abbott... (Filed With SEC on October 28, 2021)
- Sixth Amendment to Development and Supply Agreement dated November 18, 2010 between (Filed With SEC on February 12, 2021)
- Second Amendment to Commercial Supply Agreement effective as of December 2, 2016 between (Filed With SEC on February 12, 2021)
- First Amendment to Commercial Supply Agreement effective as of January 20, 2014 between (Filed With SEC on February 12, 2021)
- Commercial Supply Agreement dated December 1, 2010 between (Filed With SEC on February 12, 2021)
- License and Collaboration Agreement relating to ladiratuzumab vedotin dated September 13, 2020 between Seagen Inc. (f/k/a Seattle Genetics, Inc.) and Merck Sharp & Dohme Corp (Filed With SEC on October 30, 2020)
- Commercial Supply Agreement dated April 2, 2020 between Seattle Genetics, Inc. and Sterling Pharma Solutions Limited (Filed With SEC on July 31, 2020)
- Commercial Supply Agreement dated February 20, 2020 between Seattle Genetics, Inc. and Corden Plankstadt (Filed With SEC on July 31, 2020)
- Commercial Supply Agreement dated June 13, 2019 between Seattle Genetics, Inc. and Esteve Quimica, S.A (Filed With SEC on July 31, 2020)
- Collaboration Agreement between Seattle Genetics, Inc. and Millennium Pharmaceuticals, Inc. (a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited) dated December 14,... (Filed With SEC on February 6, 2020)
- Eleventh Amendment to Development and Supply Agreement effective July 12, 2018 between Seattle Genetics, Inc. and AbbVie Inc. (formerly part of Abbott Laboratories, Inc.) (Filed With SEC on February 6, 2020)
- Third Amendment to Commercial Supply Agreement effective as of July 1, 2019 between Seattle Genetics, Inc. and SAFC, an operating division of Sigma-Aldrich, Inc (Filed With SEC on October 30, 2019)
- Twelfth Amendment to Development and Supply Agreement, effective as of April 25, 2019 between Seattle Genetics, Inc. and AbbVie, Inc. (formerly part of Abbott Laboratories, Inc.) (Filed With SEC on July 16, 2019)
- License and Collaboration Agreement, effective October 7, 2011, between Genmab A/S and Seattle Genetics, Inc (Filed With SEC on November 6, 2017)
- Termination Agreement, dated May 4, 2017, between Immunomedics, Inc. and Seattle Genetics, Inc (Filed With SEC on August 1, 2017)
- TENTH AMENDMENT TO DEVELOPMENT AND SUPPLY AGREEMENT (Filed With SEC on February 21, 2017)
- Second Amendmentto SGD-1006 Commercial Supply Agreement executed on 1 December 2010 and First Amendment to Commercial Supply Agreement executed on 20 January 2014 (the First... (Filed With SEC on February 21, 2017)
- Amendment to SGD-1006 Commercial Supply Agreement executed on 1 December 2010. [*] Manufacturing Controls Price Increase (Filed With SEC on February 21, 2017)
- NINTH AMENDMENT TO DEVELOPMENT AND SUPPLY AGREEMENT (Filed With SEC on October 27, 2016)
- EIGHTH AMENDMENT TODEVELOPMENT AND SUPPLY AGREEMENT (Filed With SEC on July 30, 2015)
- SEATTLE GENETICS, INC. DEVELOPMENT AND SUPPLY AGREEMENT (Filed With SEC on February 27, 2015)
- SEVENTH AMENDMENT TO DEVELOPMENT AND SUPPLY AGREEMENT (Filed With SEC on February 27, 2013)
- SIXTH AMENDMENT TO DEVELOPMENT AND SUPPLY AGREEMENT (Filed With SEC on November 4, 2011)
- FIFTH AMENDMENT TO DEVELOPMENT AND SUPPLY AGREEMENT (Filed With SEC on November 4, 2011)
- FOURTH AMENDMENT TO DEVELOPMENT AND SUPPLY AGREEMENT (Filed With SEC on November 4, 2011)
- THIRD AMENDMENT TO DEVELOPMENT AND SUPPLY AGREEMENT (Filed With SEC on November 4, 2011)
- SECOND AMENDMENT TO DEVELOPMENT AND SUPPLY AGREEMENT (Filed With SEC on November 4, 2011)
- COMMERCIAL SUPPLY AGREEMENT SGD-1006 (Filed With SEC on November 4, 2011)
- AMENDMENT TO COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on March 12, 2010)
- COLLABORATION AGREEMENT (Filed With SEC on November 7, 2008)
- COLLABORATION AGREEMENT (Filed With SEC on May 8, 2007)
- COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on May 8, 2007)
- BIOPHARMACEUTICAL MANUFACTURING SERVICES AGREEMENT (Filed With SEC on August 8, 2006)
- COLLABORATION AGREEMENT (Filed With SEC on August 9, 2005)
- MANUFACTURING AND SUPPLY AGREEMENT BETWEEN (Filed With SEC on August 9, 2005)
